M. ÖZDEDE And A. T. Güven, "Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment," Internal and Emergency Medicine , vol.19, no.3, pp.879-881, 2024
ÖZDEDE, M. And Güven, A. T. 2024. Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment. Internal and Emergency Medicine , vol.19, no.3 , 879-881.
ÖZDEDE, M., & Güven, A. T., (2024). Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment. Internal and Emergency Medicine , vol.19, no.3, 879-881.
ÖZDEDE, MURAT, And Alper Tuna Güven. "Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment," Internal and Emergency Medicine , vol.19, no.3, 879-881, 2024
ÖZDEDE, MURAT And Güven, Alper T. . "Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment." Internal and Emergency Medicine , vol.19, no.3, pp.879-881, 2024
ÖZDEDE, M. And Güven, A. T. (2024) . "Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment." Internal and Emergency Medicine , vol.19, no.3, pp.879-881.
@article{article, author={MURAT ÖZDEDE And author={Alper Tuna Güven}, title={Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors: comment}, journal={Internal and Emergency Medicine}, year=2024, pages={879-881} }